Vaccines Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Vaccines Market
Vaccines Market: By Type (Monovalent, Multivalent); By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Others); By Disease Indication (Pneumococcal Disease, DTP, Others); By End User (Paediatrics, Adults) & Region - Forecast(2018 - 2023)
Report Code : HCR 0711
Updated Date: 31 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Vaccines Market – Overview
2. Executive Summary 
3. Vaccines Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Vaccines Market– Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance vaccines
      4.1.2. Growing prevalence of diseases
   4.2. Restraints
      4.2.1. Higher cost of research and development
      4.2.2. Side effects of vaccines
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Vaccines Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Vaccines Market, By Type
   6.1. Monovalent Vaccines 
   6.2. Multivalent Vaccines 
7. Vaccines Market, By Technology
   7.1. Conjugate Vaccines 
   7.2. Inactivated and Subunit Vaccines 
   7.3. Live Attenuated Vaccines 
   7.4. Toxoid Vaccines 
   7.5. Recombinant Vaccines 
8. Vaccines Market, By Diseases Indication 
   8.1. Pneumococcal Disease 
   8.2. DTP 
   8.3. Influenza 
   8.4. Human Papilloma Virus 
   8.5. Meningococcal Disease 
   8.6. Polio 
   8.7. Rotavirus 
   8.8. Hepatitis 
   8.9. MMR 
   8.10. Varicella 
   8.11. Others
9. Vaccines Market, By End-User 
   9.1. Paediatrics
   9.2. Adults
10. Vaccines Market, By Geography
   10.1. Europe
      10.1.1. Germany
      10.1.2. France
      10.1.3. Italy
      10.1.4. Spain
      10.1.5. Russia
      10.1.6. U.K.
      10.1.7. Rest of Europe
   10.2. Asia Pacific
      10.2.1. China
      10.2.2. India
      10.2.3. Japan
      10.2.4. South Korea
      10.2.5. Rest of Asia-Pacific
   10.3. North America 
      10.3.1. U.S.
      10.3.2. Canada
      10.3.3. Mexico
   10.4. Rest of the World (RoW)
      10.4.1. Brazil
      10.4.2. Rest of RoW
11. Vaccines Market – Entropy
   11.1. Expansion
   11.2. Technological Developments
   11.3. Merger & Acquisitions, and Joint Ventures
   11.4. Supply- Contract
12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   12.1. Medimmune, LLC. (A Subsidiary of Astrazeneca) 
   12.2. Astellas Pharma Inc. 
   12.3. Serum Institute of India
   12.4. Emergent Biosolutions, Inc.
   12.5. Merck & Co., Inc.
   12.6. Johnson & Johnson
   12.7. Sanofi Pasteur 
   12.8. CSL Limited
   12.9. Pfizer, Inc. 
   12.10. Glaxosmithkline, PLC.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
The vaccination saves millions of lives including adults, children, and animals, and provides them a better and healthier life. Globally, development of efficient and advanced vaccines, rise in the awareness among people regarding the benefits of immunization, increasing government initiatives across the globe, growing prevalence of diseases, and increasing demand for better healthcare infrastructure are the prime growth drivers of the vaccines market. In addition, an increase in adoption of vaccines in emerging economies such as China, India and others, will create new opportunities for the vaccines market. However, higher cost of research and development, and risk of side effects of vaccines are the key restraints for the vaccines market.

 Vaccines Market

Geographically, North America dominated the vaccines market, with approximately half of the world’s procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing population, rise in consumer awareness, growing disposable income & healthcare expenditure, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the end users, paediatrics segment has the highest market share in the vaccines market due to higher prevalence of diseases.

This report identifies the vaccines market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the vaccines market.

This report segments the vaccines market on the basis of type, technology, disease indication, end user, and regional market as follows:
  • Vaccines Market, By Type: Monovalent Vaccines, and Multivalent Vaccines
  • Vaccines Market, By Technology: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, and Recombinant Vaccines
  • Vaccines Market, By Disease Indication: Pneumococcal Disease, DTP, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Hepatitis, MMR, Varicella, and Others
  • The report has focused study on vaccines market by basis of end user such as: Paediatrics, and Adults
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the vaccines market. Some of the major companies’ profiles in detail are as follows:
  • Medimmune, LLC. (A Subsidiary of Astrazeneca) 
  • Astellas Pharma Inc. 
  • Serum Institute of India
  • Emergent Biosolutions, Inc.
  • Merck & Co., Inc.
List of Tables:

Table 1: Vaccines Market Overview 2017-2023
Table 2: Vaccines Market Leader Analysis 2017-2018 (US$)
Table 3: Vaccines Market Product Analysis 2017-2018 (US$)
Table 4: Vaccines Market End User Analysis 2017-2018 (US$)
Table 5: Vaccines Market Patent Analysis 2013-2018* (US$)
Table 6: Vaccines Market Financial Analysis 2017-2018 (US$)
Table 7: Vaccines Market Driver Analysis 2017-2018 (US$)
Table 8: Vaccines Market Challenges Analysis 2017-2018 (US$)
Table 9: Vaccines Market Constraint Analysis 2017-2018 (US$)
Table 10: Vaccines Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Vaccines Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Vaccines Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Vaccines Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Vaccines Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Vaccines Market Value Chain Analysis 2017-2018 (US$)
Table 16: Vaccines Market Pricing Analysis 2018-2023 (US$)
Table 17: Vaccines Market Opportunities Analysis 2018-2023 (US$)
Table 18: Vaccines Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Vaccines Market Supplier Analysis 2017-2018 (US$)
Table 20: Vaccines Market Distributor Analysis 2017-2018 (US$)
Table 21: Vaccines Market Trend Analysis 2017-2018 (US$)
Table 22: Vaccines Market Size 2017 (US$)
Table 23: Vaccines Market Forecast Analysis 2018-2023 (US$)
Table 24: Vaccines Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 26: Vaccines Market By Type, Revenue & Volume, By Monovalent Vaccines, 2018-2023 ($)
Table 27: Vaccines Market By Type, Revenue & Volume, By Multivalent Vaccines, 2018-2023 ($)
Table 28: Vaccines Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 29: Vaccines Market By Technology, Revenue & Volume, By Conjugate Vaccines, 2018-2023 ($)
Table 30: Vaccines Market By Technology, Revenue & Volume, By Inactivated and Subunit Vaccines, 2018-2023 ($)
Table 31: Vaccines Market By Technology, Revenue & Volume, By Live Attenuated Vaccines, 2018-2023 ($)
Table 32: Vaccines Market By Technology, Revenue & Volume, By Toxoid Vaccines, 2018-2023 ($)
Table 33: Vaccines Market By Technology, Revenue & Volume, By Recombinant Vaccines, 2018-2023 ($)
Table 34: Vaccines Market, Revenue & Volume, By Diseases Indication, 2018-2023 ($)
Table 35: Vaccines Market By Diseases Indication, Revenue & Volume, By Pneumococcal Disease, 2018-2023 ($)
Table 36: Vaccines Market By Diseases Indication, Revenue & Volume, By DTP, 2018-2023 ($)
Table 37: Vaccines Market By Diseases Indication, Revenue & Volume, By Influenza, 2018-2023 ($)
Table 38: Vaccines Market By Diseases Indication, Revenue & Volume, By Human Papilloma Virus, 2018-2023 ($)
Table 39: Vaccines Market By Diseases Indication, Revenue & Volume, By Meningococcal Disease, 2018-2023 ($)
Table 40: Vaccines Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 41: Vaccines Market By End User, Revenue & Volume, By Paediatrics, 2018-2023 ($)
Table 42: Vaccines Market By End User, Revenue & Volume, By Adults, 2018-2023 ($)
Table 43: North America Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 44: North America Vaccines Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 45: North America Vaccines Market, Revenue & Volume, By Diseases Indication, 2018-2023 ($)
Table 46: North America Vaccines Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 47: South america Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 48: South america Vaccines Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 49: South america Vaccines Market, Revenue & Volume, By Diseases Indication, 2018-2023 ($)
Table 50: South america Vaccines Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 51: Europe Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 52: Europe Vaccines Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 53: Europe Vaccines Market, Revenue & Volume, By Diseases Indication, 2018-2023 ($)
Table 54: Europe Vaccines Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 55: APAC Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 56: APAC Vaccines Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 57: APAC Vaccines Market, Revenue & Volume, By Diseases Indication, 2018-2023 ($)
Table 58: APAC Vaccines Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 59: Middle East & Africa Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 60: Middle East & Africa Vaccines Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 61: Middle East & Africa Vaccines Market, Revenue & Volume, By Diseases Indication, 2018-2023 ($)
Table 62: Middle East & Africa Vaccines Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 63: Russia Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 64: Russia Vaccines Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 65: Russia Vaccines Market, Revenue & Volume, By Diseases Indication, 2018-2023 ($)
Table 66: Russia Vaccines Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 67: Israel Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 68: Israel Vaccines Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 69: Israel Vaccines Market, Revenue & Volume, By Diseases Indication, 2018-2023 ($)
Table 70: Israel Vaccines Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 71: Top Companies 2017 (US$) Vaccines Market, Revenue & Volume
Table 72: Product Launch 2017-2018 Vaccines Market, Revenue & Volume
Table 73: Mergers & Acquistions 2017-2018 Vaccines Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Vaccines Market 2017-2023
Figure 2: Market Share Analysis for Vaccines Market 2017 (US$)
Figure 3: Product Comparison in Vaccines Market 2017-2018 (US$)
Figure 4: End User Profile for Vaccines Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Vaccines Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Vaccines Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Vaccines Market 2017-2018
Figure 8: Ecosystem Analysis in Vaccines Market 2017
Figure 9: Average Selling Price in Vaccines Market 2017-2023
Figure 10: Top Opportunites in Vaccines Market 2017-2018
Figure 11: Market Life Cycle Analysis in Vaccines Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy Type Vaccines Market Revenue, 2018-2023 ($)
Figure 13: GlobalBy Technology Vaccines Market Revenue, 2018-2023 ($)
Figure 14: GlobalBy Diseases Indication Vaccines Market Revenue, 2018-2023 ($)
Figure 15: GlobalBy End User Vaccines Market Revenue, 2018-2023 ($)
Figure 16: Global Vaccines Market - By Geography
Figure 17: Global Vaccines Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 18: Global Vaccines Market CAGR, By Geography, 2018-2023 (%)
Figure 19: North America Vaccines Market Value & Volume, 2018-2023 ($)
Figure 20: US Vaccines Market Value & Volume, 2018-2023 ($)
Figure 21: US GDP and Population, 2017-2018 ($)
Figure 22: US GDP – Composition of 2017, By Sector of Origin
Figure 23: US Export and Import Value & Volume, 2017-2018 ($)
Figure 24: Canada Vaccines Market Value & Volume, 2018-2023 ($)
Figure 25: Canada GDP and Population, 2017-2018 ($)
Figure 26: Canada GDP – Composition of 2017, By Sector of Origin
Figure 27: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 28: Mexico Vaccines Market Value & Volume, 2018-2023 ($)
Figure 29: Mexico GDP and Population, 2017-2018 ($)
Figure 30: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 31: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 32: South America Vaccines Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 33: Brazil Vaccines Market Value & Volume, 2018-2023 ($)
Figure 34: Brazil GDP and Population, 2017-2018 ($)
Figure 35: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 36: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 37: Venezuela Vaccines Market Value & Volume, 2018-2023 ($)
Figure 38: Venezuela GDP and Population, 2017-2018 ($)
Figure 39: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 40: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 41: Argentina Vaccines Market Value & Volume, 2018-2023 ($)
Figure 42: Argentina GDP and Population, 2017-2018 ($)
Figure 43: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 44: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 45: Ecuador Vaccines Market Value & Volume, 2018-2023 ($)
Figure 46: Ecuador GDP and Population, 2017-2018 ($)
Figure 47: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 48: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 49: Peru Vaccines Market Value & Volume, 2018-2023 ($)
Figure 50: Peru GDP and Population, 2017-2018 ($)
Figure 51: Peru GDP – Composition of 2017, By Sector of Origin
Figure 52: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 53: Colombia Vaccines Market Value & Volume, 2018-2023 ($)
Figure 54: Colombia GDP and Population, 2017-2018 ($)
Figure 55: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 56: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 57: Costa Rica Vaccines Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 58: Costa Rica GDP and Population, 2017-2018 ($)
Figure 59: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 60: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 61: Europe Vaccines Market Value & Volume, 2018-2023 ($)
Figure 62: U.K Vaccines Market Value & Volume, 2018-2023 ($)
Figure 63: U.K GDP and Population, 2017-2018 ($)
Figure 64: U.K GDP – Composition of 2017, By Sector of Origin
Figure 65: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 66: Germany Vaccines Market Value & Volume, 2018-2023 ($)
Figure 67: Germany GDP and Population, 2017-2018 ($)
Figure 68: Germany GDP – Composition of 2017, By Sector of Origin
Figure 69: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 70: Italy Vaccines Market Value & Volume, 2018-2023 ($)
Figure 71: Italy GDP and Population, 2017-2018 ($)
Figure 72: Italy GDP – Composition of 2017, By Sector of Origin
Figure 73: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 74: France Vaccines Market Value & Volume, 2018-2023 ($)
Figure 75: France GDP and Population, 2017-2018 ($)
Figure 76: France GDP – Composition of 2017, By Sector of Origin
Figure 77: France Export and Import Value & Volume, 2017-2018 ($)
Figure 78: Netherlands Vaccines Market Value & Volume, 2018-2023 ($)
Figure 79: Netherlands GDP and Population, 2017-2018 ($)
Figure 80: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 81: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 82: Belgium Vaccines Market Value & Volume, 2018-2023 ($)
Figure 83: Belgium GDP and Population, 2017-2018 ($)
Figure 84: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 85: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 86: Spain Vaccines Market Value & Volume, 2018-2023 ($)
Figure 87: Spain GDP and Population, 2017-2018 ($)
Figure 88: Spain GDP – Composition of 2017, By Sector of Origin
Figure 89: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 90: Denmark Vaccines Market Value & Volume, 2018-2023 ($)
Figure 91: Denmark GDP and Population, 2017-2018 ($)
Figure 92: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 93: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 94: APAC Vaccines Market Value & Volume, 2018-2023 ($)
Figure 95: China Vaccines Market Value & Volume, 2018-2023
Figure 96: China GDP and Population, 2017-2018 ($)
Figure 97: China GDP – Composition of 2017, By Sector of Origin
Figure 98: China Export and Import Value & Volume, 2017-2018 ($) Vaccines Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 99: Australia Vaccines Market Value & Volume, 2018-2023 ($)
Figure 100: Australia GDP and Population, 2017-2018 ($)
Figure 101: Australia GDP – Composition of 2017, By Sector of Origin
Figure 102: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 103: South Korea Vaccines Market Value & Volume, 2018-2023 ($)
Figure 104: South Korea GDP and Population, 2017-2018 ($)
Figure 105: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 106: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 107: India Vaccines Market Value & Volume, 2018-2023 ($)
Figure 108: India GDP and Population, 2017-2018 ($)
Figure 109: India GDP – Composition of 2017, By Sector of Origin
Figure 110: India Export and Import Value & Volume, 2017-2018 ($)
Figure 111: Taiwan Vaccines Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 112: Taiwan GDP and Population, 2017-2018 ($)
Figure 113: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 114: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 115: Malaysia Vaccines Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 116: Malaysia GDP and Population, 2017-2018 ($)
Figure 117: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 118: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 119: Hong Kong Vaccines Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 120: Hong Kong GDP and Population, 2017-2018 ($)
Figure 121: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 122: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 123: Middle East & Africa Vaccines Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 124: Russia Vaccines Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 125: Russia GDP and Population, 2017-2018 ($)
Figure 126: Russia GDP – Composition of 2017, By Sector of Origin
Figure 127: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 128: Israel Vaccines Market Value & Volume, 2018-2023 ($)
Figure 129: Israel GDP and Population, 2017-2018 ($)
Figure 130: Israel GDP – Composition of 2017, By Sector of Origin
Figure 131: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 132: Entropy Share, By Strategies, 2017-2018* (%) Vaccines Market
Figure 133: Developments, 2017-2018* Vaccines Market
Figure 134: Company 1 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 135: Company 1 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 136: Company 1 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 137: Company 2 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 138: Company 2 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 139: Company 2 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 140: Company 3 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 141: Company 3 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 142: Company 3 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 143: Company 4 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 144: Company 4 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 145: Company 4 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 146: Company 5 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 147: Company 5 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 148: Company 5 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 149: Company 6 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 150: Company 6 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 151: Company 6 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 152: Company 7 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 153: Company 7 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 154: Company 7 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 155: Company 8 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 156: Company 8 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 157: Company 8 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 158: Company 9 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 159: Company 9 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 160: Company 9 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 161: Company 10 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 162: Company 10 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 163: Company 10 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 164: Company 11 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 165: Company 11 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 166: Company 11 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 167: Company 12 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 168: Company 12 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 169: Company 12 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 170: Company 13 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 171: Company 13 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 172: Company 13 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 173: Company 14 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 174: Company 14 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 175: Company 14 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 176: Company 15 Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 177: Company 15 Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 178: Company 15 Vaccines Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll